Cell therapy is emerging as a potential treatment for conditions like Crohn
Cell therapy is emerging as a potential treatment for conditions like Crohn
Cell therapy is emerging as a potential treatment for conditions like Crohn's disease, ulcerative colitis, and liver cirrhosis. Mesenchymal stem cells (MSCs), known for their anti-inammatory properties, are showing promise in reducing inammation and aiding tissue regeneration in the gastrointestinal tract. For liver diseases, stem cells could provide as a bridging therapy alternative to transplantation by regenerating damaged liver cells, offering new hope to patients with chronic liver failure.
Chronic liver disease (CLD), mainly those arising from hepatitis viral infection, toxic injury, alcohol abuse, metabolic disorders, or genetic defect, is an important global health concern. There is a high risk of progressing to advanced fibrosis, cirrhosis, and cirrhosis-related complications including acute-on-chronic liver failure (ACLF) and hepatocellular carcinoma.